Explore new findings on frailty in systemic sclerosis, revealing its prevalence, dynamic progression, and impact on patient ...

Frailty among patients with systemic sclerosis significantly increases the risk for mortality by nearly 10-fold, but shows ...

Acute and chronic renal diseases remain common complications of systemic sclerosis. Although treatment for acute scleroderma renal crisis may arrest the rapid progression of renal disease ...

Scleroderma is classified as a rare ... rheumatologist at a nearby university medical department who diagnoses systemic sclerosis. She and her husband are frightened, especially when she is ...

A history of infertility without fertility treatment was associated with a higher future risk of SARD, independent of ...

Although systemic sclerosis is not inherited, a genetic predisposition plays an important role in its development. Scleroderma is a systemic autoimmune disease that affects the skin and other organs ...

Tyr Pharma's stock surged on positive data for pulmonary sarcoidosis treatment, but cash balance risk keeps investors ...

The mildest forms of localised scleroderma may improve on their own over time, while systemic sclerosis can affect blood circulation and the internal organs as well, sometimes leading to life ...

Ianalumab is under clinical development by Novartis and currently in Phase II for Systemic Sclerosis (Scleroderma). According to GlobalData, Phase II drugs for Systemic Sclerosis (Scleroderma) have a ...

Stem cells themselves or the exosomes secreted by them can act on the diseased tissues of systemic sclerosis and improve the inflammation and fibrosis of these tissues. 2.2 Therapeutic effects of ...